Iradimed's market cap is currently ―. The company's EPS TTM is €; its P/E ratio is ―; and it has a dividend yield of 0.37%. Iradimed is scheduled to report earnings on August 1, 2024, and the estimated EPS forecast is €―. See an overview of income statement, balance sheet, and cash flow financials.

	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23
Income Statement	-
Total Revenue	$ 17.60M	$ 17.45M	$ 16.50M	$ 16.13M	$ 15.48M
Gross Profit	$ 13.39M	$ 13.41M	$ 12.84M	$ 16.13M	$ 11.72M
EBIT	$ 5.24M	$ 5.68M	$ 6.41M	$ 5.30M	$ 4.35M
EBITDA	$ 5.47M	$ 5.89M	$ 6.60M	$ 5.49M	$ 4.53M
Net Income Common Stockholders	$ 4.14M	$ 4.54M	$ 5.07M	$ 4.18M	$ 3.41M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 45.13M	$ 49.76M	$ 46.75M	$ 45.82M	$ 42.78M
Total Assets	$ 88.01M	$ 92.16M	$ 87.41M	$ 81.43M	$ 75.62M
Total Debt	$ 1.94M	$ 2.04M	$ 2.15M	$ 2.25M	$ 2.35M
Net Debt	$ -43.19M	$ -47.72M	$ -44.60M	$ -43.58M	$ -40.43M
Total Liabilities	$ 11.89M	$ 20.74M	$ 12.84M	$ 12.43M	$ 11.28M
Stockholders Equity	$ 76.12M	$ 71.42M	$ 74.57M	$ 69.00M	$ 64.34M
Cash Flow	-
Free Cash Flow	$ 3.40M	$ 3.28M	$ 953.66K	$ 3.14M	$ -1.91M
Operating Cash Flow	$ 3.88M	$ 3.91M	$ 1.39M	$ 3.51M	$ 4.65M
Investing Cash Flow	$ -478.80K	$ -632.82K	$ -439.02K	$ -378.31K	$ -6.56M
Financing Cash Flow	$ -8.04M	$ -262.59K	$ -31.37K	$ -89.77K	$ -13.27M

Currency in USD

Iradimed Earnings and Revenue History

Income Statement >

Iradimed Debt to Assets

Balance Sheet >

Iradimed Cash Flow

Cash Flow >

Iradimed Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing